• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种癌胚抗原交叉反应抗原:吸收同一抗癌胚抗原血清的差异

Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.

作者信息

Ferrara R M, Biancardi C, Cavalca V, Botta M, Bailo M, Bartorelli A

出版信息

Cancer Detect Prev. 1987;10(1-2):101-8.

PMID:3568003
Abstract

A factor that cross reacts with the carcinoembryonic antigen (CEA), which we call P factor, was isolated from normal human plasma. To demonstrate the difference between this P factor and the nonspecific cross-reacting antigen (NCA), the same anti-CEA serum was absorbed in an identical manner with both the antigens. Absorption was checked by immunohistochemistry by the beta-galactosidase procedure on sections of colonic adenocarcinoma and normal colonic mucosa. The unabsorbed antiserum recognizes both tissues; after absorption with NCA the staining becomes paler on both tissues, but maintains color on the normal colonic mucosa and granulocytes. Only absorption with the P factor will give an unstained field of normal colonic mucosa, thus revealing the tumor structure. Data obtained by us suggest that the NCA (tissue extract) is an antigen that is not suitable to the absorption of anti-CEA serum for immunocytochemistry techniques, whereas the P factor (plasma extract) appears to be utilizable with good results.

摘要

从正常人血浆中分离出一种与癌胚抗原(CEA)发生交叉反应的因子,我们称之为P因子。为了证明这种P因子与非特异性交叉反应抗原(NCA)之间的差异,用这两种抗原以相同方式吸收同一份抗CEA血清。通过免疫组织化学β-半乳糖苷酶法在结肠腺癌和正常结肠黏膜切片上检查吸收情况。未吸收的抗血清可识别这两种组织;用NCA吸收后,两种组织上的染色都变浅,但正常结肠黏膜和粒细胞上仍保持颜色。只有用P因子吸收才会使正常结肠黏膜出现无染色区域,从而显示出肿瘤结构。我们获得的数据表明,NCA(组织提取物)是一种不适用于免疫细胞化学技术中抗CEA血清吸收的抗原,而P因子(血浆提取物)似乎可产生良好效果。

相似文献

1
Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.两种癌胚抗原交叉反应抗原:吸收同一抗癌胚抗原血清的差异
Cancer Detect Prev. 1987;10(1-2):101-8.
2
Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.对人前列腺癌进行癌胚抗原、非特异性交叉反应抗原、β-绒毛膜促性腺激素和前列腺特异性抗原的免疫细胞化学评估。
Cancer Res. 1984 Jan;44(1):285-92.
3
Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.对人食管肿瘤及癌前病变进行β-绒毛膜促性腺激素、胎盘催乳素、甲胎蛋白、癌胚抗原和非特异性交叉反应抗原的免疫细胞化学评估。
Cancer Res. 1986 Jun;46(6):2936-43.
4
Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.肿瘤组织中癌胚抗原与胎粪及成人粪便中相关抗原的免疫化学差异。
Cancer Res. 1982 May;42(5):2012-8.
5
Antigenic variants of the nonspecific cross-reacting antigen (NCA).
J Immunol. 1986 Aug 1;137(3):839-45.
6
Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.人血清中针对癌胚抗原(CEA)及相关抗原NCA的天然抗体。
Anticancer Res. 1987 Nov-Dec;7(6):1229-33.
7
Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.多种人类肿瘤细胞系合成的癌胚抗原和非特异性交叉反应抗原的产生动力学及免疫化学特性
Jpn J Cancer Res. 1986 May;77(5):462-72.
8
Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.一株源自人胰腺肿瘤的连续细胞系共同产生癌胚抗原和非特异性交叉反应抗原。
J Natl Cancer Inst. 1982 Aug;69(2):401-8.
9
Anti-carcinoembryonic antigen sera acquiring higher tumor specificity by absorption with a plasma factor.通过与血浆因子吸收获得更高肿瘤特异性的抗癌胚抗原血清。
Biomed Pharmacother. 1985;39(8):433-41.
10
Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.膀胱癌中非特异性交叉反应抗原和癌胚抗原(CEA)的免疫组织化学评估
Anticancer Res. 1989 Mar-Apr;9(2):319-26.